GRAL GRAIL Inc.

  1. Stocks
  2. Healthcare
  3. NASDAQ: GRAL

Price (delayed)

$59.85

Market cap

$2.57B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$10.31

Enterprise value

$2.54B

?
Relative Growth: Rel. Growth: 69
Relative Strength: Rel. Strength: 73
Relative Valuation: Rel. Valuation: 7
Relative Profitability: Rel. Profitability: 20

GRAIL, LLC, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, ...

Highlights
GRAL's EPS has surged by 83% year-on-year and by 7% since the previous quarter
The net income has surged by 79% year-on-year and by 3.2% since the previous quarter
GRAIL's quick ratio has increased by 22% YoY but it has decreased by 2.5% QoQ
The equity has increased by 3.6% year-on-year but it has declined by 3% since the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Peers: ILMN LH DGX BIO

Key stats

What are the main financial stats of GRAL

GRAL stock price

How has the GRAIL stock price performed over time
Intraday
-0.52%
1 week
-0.22%
1 month
-3.44%
1 year
42.77%
YTD
-30.07%
QTD
15.81%

Financial performance

How have GRAIL's revenue and profit performed over time
Revenue
$156.12M
Gross profit
-$56.95M
Operating income
-$544.32M
Net income
-$395.33M
Gross margin
-36.5%
Net margin
-253.2%
GRAIL's net margin has soared by 83% YoY and by 9% from the previous quarter
The net income has surged by 79% year-on-year and by 3.2% since the previous quarter
GRAIL's operating margin has surged by 78% YoY and by 9% QoQ
GRAIL's operating income has soared by 74% YoY and by 3.2% from the previous quarter

Price vs fundamentals

How does GRAL's price correlate with its fundamentals

Growth

What is GRAIL's growth rate over time

Valuation

What is GRAIL stock price valuation
P/E
N/A
P/B
0.93
P/S
15.58
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
16.29
GRAL's EPS has surged by 83% year-on-year and by 7% since the previous quarter
The stock's price to book (P/B) is 7% less than its last 4 quarters average of 1.0
The equity has increased by 3.6% year-on-year but it has declined by 3% since the previous quarter
GRAIL's revenue has increased by 19% YoY and by 6% from the previous quarter
GRAL's P/S is 2% below its last 4 quarters average of 15.9

Efficiency

How efficient is GRAIL business performance
GRAL's return on invested capital has surged by 84% year-on-year and by 9% since the previous quarter
GRAL's return on sales has surged by 79% year-on-year and by 9% since the previous quarter
The company's return on equity has surged by 78% YoY and by 4.1% QoQ
GRAL's return on assets has surged by 77% year-on-year and by 3.4% since the previous quarter

Dividends

What is GRAL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GRAL.

Financial health

How did GRAIL financials performed over time
GRAIL's total liabilities has decreased by 30% YoY and by 12% QoQ
GRAIL's quick ratio has increased by 22% YoY but it has decreased by 2.5% QoQ
GRAIL's debt is 98% less than its equity
The debt to equity has declined by 33% year-on-year
GRAIL's debt has decreased by 21% YoY and by 7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.